SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes the sessions on Biomarkers and Correlates, and Human Challenge Models. Summaries of all sessions from the 4th Global Forum are compiled in a special supplement of Tuberculosis. [August 2016, Vol 99, Supp S1, S1–S30]
Tuberculosis (TB) remains a global health threat, with 8.6 million new cases and 1.3 million deaths ...
SummaryThe quest for a vaccine that could have a major impact in reducing the current global burden ...
CITATION: Kaufmann, S. H. E. et al. 2017. TBVAC2020 : advancing tuberculosis vaccines from discovery...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
The most effective intervention for the control of infectious disease is vaccination. The BCG vaccin...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
While much progress has been made in the fight against the scourge of tuberculosis (TB), we are stil...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
AbstractTB is now the single pathogen that causes the greatest mortality in the world, at over 1.6 m...
TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC...
TB is now the leading, global cause of death due to a single infectious microbe. To achieve the End ...
Background: Tuberculosis (TB) is an enduring health problem worldwide and the emerging threat of Mul...
Tuberculosis (TB) is one of the greatest global health challenges society faces. BCG, the only licen...
TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC...
Tuberculosis (TB) remains a global health threat, with 8.6 million new cases and 1.3 million deaths ...
SummaryThe quest for a vaccine that could have a major impact in reducing the current global burden ...
CITATION: Kaufmann, S. H. E. et al. 2017. TBVAC2020 : advancing tuberculosis vaccines from discovery...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
The most effective intervention for the control of infectious disease is vaccination. The BCG vaccin...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
While much progress has been made in the fight against the scourge of tuberculosis (TB), we are stil...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
AbstractTB is now the single pathogen that causes the greatest mortality in the world, at over 1.6 m...
TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC...
TB is now the leading, global cause of death due to a single infectious microbe. To achieve the End ...
Background: Tuberculosis (TB) is an enduring health problem worldwide and the emerging threat of Mul...
Tuberculosis (TB) is one of the greatest global health challenges society faces. BCG, the only licen...
TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC...
Tuberculosis (TB) remains a global health threat, with 8.6 million new cases and 1.3 million deaths ...
SummaryThe quest for a vaccine that could have a major impact in reducing the current global burden ...
CITATION: Kaufmann, S. H. E. et al. 2017. TBVAC2020 : advancing tuberculosis vaccines from discovery...